Clinical Trial

Investigation Into the Dynamic Variations of End-Tidal Carbon Monoxide Concentration (ETCOc) in Neonates Utilizing Non-Dispersive Infrared Spectroscopy and Its Implications for Jaundice Management

Study acronym: ETCO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 16, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to ascertain the diagnostic threshold of end-tidal carbon monoxide (ETCOc, adjusted for ambient CO levels) within the first three days postpartum, stratified by neonatal age at birth. Additionally, the study aims to evaluate the concordance of the risk range of ETCOc, as measured by non-dispersive infrared spectroscopy, with existing literature, and to assess the reliability of this technology in the management of neonatal hyperbilirubinemia.
Trial Details
NCT Number NCT07346976
Lead Sponsor The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Conditions Neonatal Hyperbilirubinemia
Enrollment 100 participants
Start Date 2025-12-05
Primary Completion 2026-07-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-16